The agenda is:
- Preparation of positions on drug evaluation:
Inrebic (fedratinibum) under the drug program: "Treatment of primary myelofibrosis and...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
